Advertisement

Reactions Weekly

, Volume 1779, Issue 1, pp 217–217 | Cite as

Sofosbuvir/velpatasvir/voxilaprevir

de novo multicentric hepatocellular carcinoma: case report
Case report
  • 42 Downloads

Reference

  1. Llaneras J, et al. Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C previously treated with DAAs. Journal of Hepatology 71: 666-672, No. 4, Oct 2019. Available from: URL: http://doi.org/10.1016/j.jhep.2019.06.002 - Spain

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations